The Trip Report by Beckley Waves
The Trip Report
#36 Dillan DiNardo: Engineering Consciousness with Psychedelics and AI
0:00
Current time: 0:00 / Total time: -40:51
-40:51

#36 Dillan DiNardo: Engineering Consciousness with Psychedelics and AI

Before we dive in, please fill out the below brief reader survey—it takes 60 seconds—to help us better understand what you like and would like to see more of from The Trip Report in 2025!

The Trip Report Reader Survey


Welcome back to The Trip Report Podcast, a production of Beckley Waves.

Today, I am speaking with Dillan DiNardo, CEO of Mindstate Design Labs, an innovative drug development company taking a unique approach to developing next-generation psychedelic medicines.

Mindstate's approach builds on the legacy of Sasha and Ann Shulgin, the pioneering chemists often referred to as the godparents of psychedelics. The company's scientific foundation comes from Dr. Tom Ray, a polymath scientist and friend and collaborator of the Shulgins.

What makes Mindstate's approach unique is its systematic analysis of both pharmacological and phenomenological data—studying not just how drugs interact with receptors in the brain, but also the subjective experiences they produce. This builds on decades of carefully documented experiences from psychonauts around the world.

The company is developing what they call a "primer-probe" approach, using carefully selected combinations of compounds to achieve specific experiential effects. Their lead candidate, Moxie (MSD-1), recently received FDA clearance to begin human trials.

Dillan comes to this work with a background in biotech venture capital, bringing a pragmatic approach to drug development while embracing the complexity and potential of psychedelic medicines.

In this conversation, we discuss:

  • The origin story of Mindstate and their novel approach to drug development

  • How they analyze and quantify subjective psychedelic experiences

  • Their "primer-probe" methodology using drug combinations

  • The concept of "psychedelic tofu" - compounds that can amplify or modify other psychedelic effects

  • Their vision for precision-designed altered states of consciousness

  • The regulatory pathway for combination psychedelic medicines

  • The broader implications of their research for understanding consciousness

And now, I bring you my conversation with Dillan DiNardo.

Listen to the episode on Substack, Spotify, Google or Apple.

Credits:

Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary

Discussion about this podcast

The Trip Report by Beckley Waves
The Trip Report
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance.